BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Durro V, Qyra S. Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009. Virol J 2011;8:96. [PMID: 21375724 DOI: 10.1186/1743-422X-8-96] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Vasmehjani AA, Yaghubi S, Erfani Y, Hajikhezri Z, Farahmand M, Shayestehpour M, Adeli OA, Beiranvand M. Trend in Prevalence of Hepatitis B Virus Infection Among Blood Donor Individuals: An Eleven-year of Experience in Lorestan, Iran. Int J Prev Med 2020;11:178. [PMID: 33456734 DOI: 10.4103/ijpvm.IJPVM_260_18] [Reference Citation Analysis]
2 Vučetić D, Jovičić M, Maslovarić I, Bogdanović S, Antić A, Stanojković Z, Filimonović G, Ilić V. Transfusion-transmissible infections among Serbian blood donors: declining trends over the period 2005-2017. Blood Transfus 2019;17:336-46. [PMID: 30865580 DOI: 10.2450/2019.0185-18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Lindenberg Ade S, Motta-Castro AR, Puga MA, Ortiz Tanaka TS, Torres MS, Fernandes-Fitts SM, Cunha RV. Decrease in hepatitis B prevalence among blood donors in Central-West Brazil. J Venom Anim Toxins Incl Trop Dis 2013;19:7. [PMID: 23849137 DOI: 10.1186/1678-9199-19-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
4 Allain JP, Sibinga CT. Family donors are critical and legitimate in developing countries. Asian J Transfus Sci 2016;10:5-11. [PMID: 27011664 DOI: 10.4103/0973-6247.164270] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
5 Zhang Y, Fang W, Fan L, Gao X, Guo Y, Huang W, Du Y. Hepatitis B surface antigen prevalence among 12,393 rural women of childbearing age in Hainan Province, China: a cross-sectional study. Virol J 2013;10:25. [PMID: 23332007 DOI: 10.1186/1743-422X-10-25] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
6 Chandekar SA, Amonkar GP, Desai HM, Valvi N, Puranik GV. Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience. J Lab Physicians 2017;9:283-7. [PMID: 28966492 DOI: 10.4103/0974-2727.214246] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
7 Gétaz L, Casillas A, Siegrist CA, Chappuis F, Togni G, Tran NT, Baggio S, Negro F, Gaspoz JM, Wolff H. Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland's largest pre-trial prison. J Glob Health 2018;8:020407. [PMID: 30140433 DOI: 10.7189/jogh-08-020407] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
8 Abdel Messih IY, Ismail MA, Saad AA, Azer MR. The degree of safety of family replacement donors versus voluntary non-remunerated donors in an Egyptian population: a comparative study. Blood Transfus. 2014;12:159-165. [PMID: 23245714 DOI: 10.2450/2012.0115-12] [Cited by in F6Publishing: 8] [Reference Citation Analysis]